|
|
40
|
|
|
6202T
|
|
|
EPIRUBICIN 50MG INJ (INP/AHI)
|
|
|
EPIRUBICIN
|
|
|
EPIRUBICIN
|
|
|
25ML VIAL
|
|
|
BQ
|
|
|
47.71
|
|
|
47.71
|
|
|
50MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
INP
|
|
|
INTAS PHARMACEUTICALS LTD
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|